Reuters logo
BRIEF-Agile Therapeutics says it plans to resubmit its NDA for Twirla in 1H 2017
March 16, 2017 / 9:47 PM / 8 months ago

BRIEF-Agile Therapeutics says it plans to resubmit its NDA for Twirla in 1H 2017

March 16 (Reuters) - Agile Therapeutics Inc

* Agile Therapeutics announces a poster presentation of its secure phase 3 study at the contraceptive technology 2017 conference

* Agile Therapeutics Inc- plans to resubmit its new drug application for Twirla in first half of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below